General MedicationsOPHTHALMICGeneric
GENTAFAIR
GENTAMICIN SULFATE
Standard Dose
EQ 3MG BASE/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview GENTAFAIR is listed in Drugs@FDA under application 062443 (ANDA).
Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE Form and strength OINTMENT;OPHTHALMIC - EQ 3MG BASE/GM Sponsor PHARMAFAIR Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview GENTAFAIR is listed in Drugs@FDA under application 062443 (ANDA). Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE Form and strength OINTMENT;OPHTHALMIC - EQ 3MG BASE/GM Sponsor PHARMAFAIR Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.